Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Macrodosimetry and microdosimetry in radioimmunotherapy

Technical Report ·
DOI:https://doi.org/10.2172/6998879· OSTI ID:6998879
This progress report summarizes the research accomplished and its clinical implementation since July 15, 1989. To improve beta-particle dosimetry, a point-source function was developed that is valid for a wide range of beta-particle emitters. An analytical solution for beta-particle dose rates within and outside of slabs of finite thickness was validated in an experimental tumor system and is now being used in clinical radioimmunotherapy (RIT). Quantitative SPECT was validated in phantom studies, beagle dogs, and patients with Kaposi's sarcoma. It is currently being used in clinical RIT for patients with Hodgkin's disease or hepatoma. Additionally, methodologies and computer software are being developed for quantitative autoradiography to achieve absorbed-dose calculation on the cellular level. 7 refs., 1 tab.
Research Organization:
Johns Hopkins Oncology Center, Baltimore, MD (USA)
Sponsoring Organization:
DOE/ER
DOE Contract Number:
FG02-89ER60867
OSTI ID:
6998879
Report Number(s):
DOE/ER/60867-1; ON: DE90007366
Country of Publication:
United States
Language:
English

Similar Records

Macrodosimetry and microdosimetry in radioimmunotherapy. Final report, July 15, 1989 -- July 14, 1992
Technical Report · Sat Nov 30 23:00:00 EST 1991 · OSTI ID:145670

Tumor dosimetry in radioimmunotherapy: Methods of calculation for beta particles
Journal Article · Sun Feb 28 23:00:00 EST 1993 · Medical Physics; (United States) · OSTI ID:6650446

Dosimetry and quantitative radionuclide imaging in radioimmunotherapy: Final report, July 15, 1992-July 14, 1996
Technical Report · Sun Sep 01 00:00:00 EDT 1996 · OSTI ID:485934